• Explore /
  • Poster
  • / Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer.

Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer.

Abstract Poster

Authors

null

Kyle Clifford Cuneo

Radiation Oncology Department, University of Michigan Health System, Ann Arbor, MI

Kyle Clifford Cuneo , Meredith Morgan , Matthew J Schipper , Jonathan Maybaum , Mahmoud Al-Hawary , Diane M. Simeone , Vaibhav Sahai , Mark Zalupski , Theodore Steven Lawrence

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02037230

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract TPS512)

DOI

10.1200/JCO.2017.35.4_suppl.TPS512

Abstract #

TPS512

Poster Bd #

O8

Abstract Disclosures

Similar Posters

First Author: Richard Tuli

First Author: Wen Wee Ma

Poster

2016 Gastrointestinal Cancers Symposium

A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.

A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.

First Author: David Bing Zhen

First Author: Kathleen N. Moore